Inventor · disambiguated record
Dangshe Ma
Also filed as: MA DANGSHE
21 granted patents·13 pending applications·346 citations·filing 1999–2024
96Inventor score
Top patents by PatentIndex Score
34 records- 0196US11511001B2Radiolabeled anti-LAG3 antibodies for immuno-PET imagingREGENERON PHARMA·Filed 2020·Granted Nov 29, 2022·3 cites·7 claims
- 0296US10730944B2Anti-CD8 antibodies and uses thereofREGENERON PHARMA·Filed 2018·Granted Aug 4, 2020·30 cites·56 claims
- 0396US8470330B2PSMA antibodies and uses thereofMADDON PAUL J·Filed 2010·Granted Jun 25, 2013·50 cites·31 claims
- 0495US12077587B2Anti-CD8 antibodies and uses thereofREGENERON PHARMA·Filed 2022·Granted Sep 3, 2024·2 cites·19 claims
- 0595US11896682B2Radiolabeled MET binding proteins for immuno-PET imaging and methods of use thereofREGENERON PHARMA·Filed 2020·Granted Feb 13, 2024·3 cites·47 claims
- 0695US11525001B2Anti-CD8 antibodies and uses thereofREGENERON PHARMA·Filed 2020·Granted Dec 13, 2022·5 cites·56 claims
- 0795US8114965B2Compositions of PSMA antibodiesMADDON PAUL J·Filed 2007·Granted Feb 14, 2012·52 cites·47 claims
- 0894US12053534B2Radiolabeled anti-PD-L1 antibodies for immuno-PET imagingREGENERON PHARMA·Filed 2021·Granted Aug 6, 2024·2 cites·26 claims
- 0992US9695248B2PSMA antibodies and uses thereofMADDON PAUL J·Filed 2012·Granted Jul 4, 2017·9 cites·31 claims
- 1091US10905784B2Radiolabeled anti-LAG3 antibodies for immuno-PET imagingREGENERON PHARMA·Filed 2018·Granted Feb 2, 2021·9 cites·24 claims
- 1191US10736976B2Radiolabeled anti-PD-L1 antibodies for immuno-PET imagingREGENERON PHARMA·Filed 2017·Granted Aug 11, 2020·7 cites·6 claims
- 1291US9242012B2Methods for killing PSMA-expressing, taxane-resistant cancer cellsMA DANGSHE·Filed 2011·Granted Jan 26, 2016·34 cites·32 claims
- 1389US8986697B2Antibodies for the treatment of Clostridium difficile-associated infection and diseaseMA DANGSHE·Filed 2011·Granted Mar 24, 2015·23 cites·24 claims
- 1489US7850971B2PSMA antibodies and protein multimersPSMA DEV COMPANY LLC·Filed 2003·Granted Dec 14, 2010·42 cites·27 claims
- 1587US6683162B2Targeted alpha particle therapy using actinium-255 conjugatesSLOAN KETTERING INST OF CANCER·Filed 2001·Granted Jan 27, 2004·42 cites·20 claims
- 1684US10689458B2Site specific HER2 antibody drug conjugatesPFIZER·Filed 2016·Granted Jun 23, 2020·3 cites·6 claims
- 1781US2024409637A1Anti-cd8 antibodies and uses thereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 1873US9828428B2Anti-IL-13 receptor alpha 2 antibodies and antibody-drug conjugatesPFIZER·Filed 2013·Granted Nov 28, 2017·2 cites·23 claims
- 1973US2023270894A1Radiolabeled anti-lag3 antibodies for immuno-pet imagingREGENERON PHARMA·Filed 2022·Application pending·0 cites
- 2071US9289519B2Alpha emitting constructs and uses thereofSCHEINBERG DAVID A·Filed 2013·Granted Mar 22, 2016·1 cites·5 claims
- 2167US7736651B1Alpha emitting constructs and uses thereofSLOAN KETTERING INST CANCER·Filed 2000·Granted Jun 15, 2010·2 cites·5 claims
- 2267US2020345872A1Radiolabeled anti-pd-l1 antibodies for immuno-pet imagingREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 2360US6603127B1Bismuth-213 generator and uses thereofSLOAN KETTERING INST CANCER·Filed 1999·Granted Aug 5, 2003·25 cites·38 claims
- 2459US2021023094A1Psma antibody-drug conjugatesPSMA DEV COMPANY LLC·Filed 2020·Application pending·0 cites
- 2557US2020377615A1Site specific her2 antibody drug conjugatesPFIZER·Filed 2020·Application pending·0 cites
- 2654US2020069764A1Antibodies and antibody fragments for site-specific conjugationPFIZER·Filed 2019·Application pending·0 cites
- 2754US2024299601A1Radiolabeled anti-lag3 antibodies for immuno-pet imagingREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 2853US8486409B2Alpha-emitting constructs and uses thereofSCHEINBERG DAVID A·Filed 2010·Granted Jul 16, 2013·0 cites·12 claims
- 2952US2004161776A1PSMA formulations and uses thereofFiled 2003·Application pending·0 cites
- 3050US2007160617A1PSMA antibody-drug conjugatesPSMA DEV COMPANY LLC·Filed 2006·Application pending·0 cites
- 3146US2003086868A1Actinium-225 complexes and conjugates for radioimmunotherapyFiled 2001·Application pending·0 cites
- 3246US2017216452A1Antibodies and antibody fragments for site-specific conjugationPFIZER·Filed 2016·Application pending·0 cites
- 3342US2004136908A1Anti-cd19 immunotoxinsFiled 2002·Application pending·0 cites
- 3439US2015175681A1Antibodies for the treatment of clostridium difficile-associated infection and diseasePROGENICS PHARM INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Dangshe Ma files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →